{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7415,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a structured table to segment the patient population based on treatment history and specific genetic mutations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/30",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-30",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The table highlights NVL-655's superior profile in G1202R and GRLM/GRGA/GRLF activity compared to existing therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/31",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-31",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Shows superior potency and efficacy against resistant mutations compared to standard-of-care inhibitors like Lorlatinib.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/32",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-32",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a bar chart for brain penetrance and a scatter plot for selectivity index to demonstrate the drug's therapeutic profile.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/33",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-33",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "Clinical trial design slide detailing patient population, objectives, and cohort structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/34",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-34",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "BOIN stands for Bayesian Optimal Interval design.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/35",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-35",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Clinical trial baseline characteristics table.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/36",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-36",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut-off: 8 Aug 2023. Includes detailed footnotes regarding specific patient events.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/37",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-37",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart displays a line graph with error bars representing standard deviation for five different dosage cohorts (15mg to 150mg QD).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/38",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-38",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart displays patient-level data categorized by dose and mutation type, highlighting the efficacy of NVL-655 in clearing specific ALK resistance mutations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/39",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-39",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data cut-off: 8 Aug 2023. Source: Lin J.J. et al., AACR-NCI-EORTC 2023.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/40",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-40",
      "loopMatches": [
        {
          "to": 40,
          "from": 29,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5bd43550-4e7b-49ae-9310-ece1e67e14d2",
          "evidence": "Slides 29-40 present preclinical and clinical trial results for NVL-655.",
          "position": 1,
          "objective": "How can Nuvalent's therapies address the needs of patients with specific cancer mutations?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a split waterfall plot to compare two patient cohorts. It includes a detailed data table below the chart showing dose levels and prior treatment history.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/41",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart is a swimmer plot, commonly used in oncology clinical trials to visualize time-to-event data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/42",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide presents two patient case studies with MRI scans showing tumor reduction.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/43",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "product_demo",
      "function": "illustrate_case",
      "notes": "Includes clinical data points for EML4-ALK v3, G1202R, G1269A, and I1322M.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/44",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide summarizes clinical trial conclusions for a pharmaceutical asset.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/45",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a Target Product Profile (TPP) framework to define the drug's clinical value proposition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/46",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses three distinct chart types to demonstrate efficacy, selectivity, and pharmacokinetics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/47",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/48",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a hexagonal process flow diagram to illustrate the company's R&D strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/49",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-chart style visualization to show the progress of three specific drug candidates (NVL-520, NVL-655, NVL-330) through clinical development phases.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/50",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "Includes a 3D molecular structure visualization.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/51",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/52",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-61b7-743d-a081-8fe73e84f928",
      "docSlug": "98950361d0ed01dfade7335ac5268481",
      "documentTitle": "Oatly | Results Presentation Deck | 39 slides",
      "authorId": "oatly",
      "authorName": "Oatly",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/11sPAMnPJj-vicPbTbn5oTo8BoYIhPq_0eVsKj1xU-I/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODk1MDM2MWQwZWQwMWRmYWRlNzMzNWFjNTI2ODQ4MS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-61b7-743d-a081-8fe73e84f928/1",
      "deckHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928",
      "deckAnchorHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "78a17f70-8e4e-4e31-8e6d-e95466223717",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The document starts with a cover page and key takeaways, grabbing the audience's attention.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/BecKp6w-lFoMcBCljpCiEMqCIpvFt9ncZ2W_Ci95qfM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODk1MDM2MWQwZWQwMWRmYWRlNzMzNWFjNTI2ODQ4MS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/S7nakm0YHXL4Xo6LZ1pf-SLZJXUCMEqVa2Y-8EH5t-o/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODk1MDM2MWQwZWQwMWRmYWRlNzMzNWFjNTI2ODQ4MS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/dC_LhOIG4zd3qWEAyZi_7J1tUkXtN7XBmQKCs-ETPPI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODk1MDM2MWQwZWQwMWRmYWRlNzMzNWFjNTI2ODQ4MS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-61b7-743d-a081-8fe73e84f928",
      "docSlug": "98950361d0ed01dfade7335ac5268481",
      "documentTitle": "Oatly | Results Presentation Deck | 39 slides",
      "authorId": "oatly",
      "authorName": "Oatly",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "other",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-61b7-743d-a081-8fe73e84f928/2",
      "deckHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928",
      "deckAnchorHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "78a17f70-8e4e-4e31-8e6d-e95466223717",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The document starts with a cover page and key takeaways, grabbing the audience's attention.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-61b7-743d-a081-8fe73e84f928",
      "docSlug": "98950361d0ed01dfade7335ac5268481",
      "documentTitle": "Oatly | Results Presentation Deck | 39 slides",
      "authorId": "oatly",
      "authorName": "Oatly",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-61b7-743d-a081-8fe73e84f928/3",
      "deckHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928",
      "deckAnchorHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "78a17f70-8e4e-4e31-8e6d-e95466223717",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The document starts with a cover page and key takeaways, grabbing the audience's attention.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-61b7-743d-a081-8fe73e84f928",
      "docSlug": "98950361d0ed01dfade7335ac5268481",
      "documentTitle": "Oatly | Results Presentation Deck | 39 slides",
      "authorId": "oatly",
      "authorName": "Oatly",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-61b7-743d-a081-8fe73e84f928/4",
      "deckHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928",
      "deckAnchorHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "78a17f70-8e4e-4e31-8e6d-e95466223717",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The document starts with a cover page and key takeaways, grabbing the audience's attention.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-61b7-743d-a081-8fe73e84f928",
      "docSlug": "98950361d0ed01dfade7335ac5268481",
      "documentTitle": "Oatly | Results Presentation Deck | 39 slides",
      "authorId": "oatly",
      "authorName": "Oatly",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "Uses leaf icons as bullet points; includes a footnote regarding non-IFRS measures.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-61b7-743d-a081-8fe73e84f928/5",
      "deckHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928",
      "deckAnchorHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "78a17f70-8e4e-4e31-8e6d-e95466223717",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The document starts with a cover page and key takeaways, grabbing the audience's attention.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-61b7-743d-a081-8fe73e84f928",
      "docSlug": "98950361d0ed01dfade7335ac5268481",
      "documentTitle": "Oatly | Results Presentation Deck | 39 slides",
      "authorId": "oatly",
      "authorName": "Oatly",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a callout to emphasize sequential improvement in Adj. EBITDA.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-61b7-743d-a081-8fe73e84f928/6",
      "deckHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928",
      "deckAnchorHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928#slide-6",
      "loopMatches": [
        {
          "to": 8,
          "from": 6,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e54f6cf3-b9fe-4da1-8e03-900472fbfbe3",
          "evidence": "The document highlights the importance of achieving profitability and the consequences of not doing so.",
          "position": 0,
          "objective": "What are the consequences of not achieving profitability?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 6,
          "beatId": "04fb6878-2188-4d4c-9f86-828211ceb909",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "The document highlights Oatly's progress towards profitability and the need for continued growth.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-61b7-743d-a081-8fe73e84f928",
      "docSlug": "98950361d0ed01dfade7335ac5268481",
      "documentTitle": "Oatly | Results Presentation Deck | 39 slides",
      "authorId": "oatly",
      "authorName": "Oatly",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-61b7-743d-a081-8fe73e84f928/7",
      "deckHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928",
      "deckAnchorHref": "/decks/019de076-61b7-743d-a081-8fe73e84f928#slide-7",
      "loopMatches": [
        {
          "to": 8,
          "from": 6,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e54f6cf3-b9fe-4da1-8e03-900472fbfbe3",
          "evidence": "The document highlights the importance of achieving profitability and the consequences of not doing so.",
          "position": 0,
          "objective": "What are the consequences of not achieving profitability?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 6,
          "beatId": "04fb6878-2188-4d4c-9f86-828211ceb909",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "The document highlights Oatly's progress towards profitability and the need for continued growth.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}